NCT03599739View on ClinicalTrials.gov

Adjuvanted Influenza Vaccination Year 2 Follow-On Survey

CompletedOBSERVATIONAL
Enrollment

598

Participants

Timeline

Start Date

July 13, 2018

Primary Completion Date

February 15, 2019

Study Completion Date

January 25, 2023

Conditions
InfluenzaInfluenza-like IllnessInfluenza, Human
Interventions
BIOLOGICAL

Influenza

Facilities will be asked to complete a survey to evaluate the impact of the influenza vaccine choice on hospitalization risk for the 2017-2018 influenza season.

Trial Locations (1)

23510

Insight Therapeutics, LLC, Norfolk

Sponsors

Collaborators (1)

Brown University
All Listed Sponsors
collaborator

Seqirus

INDUSTRY

collaborator

Brown University

OTHER

lead

Insight Therapeutics, LLC

OTHER

NCT03599739 - Adjuvanted Influenza Vaccination Year 2 Follow-On Survey | Biotech Hunter | Biotech Hunter